Company

Enveric Biosciences, Inc.

Headquarters: Toronto, ON, Canada

Employees: 2

CEO: Dr. Joseph Edward Tucker Ph.D.

NASDAQ: ENVB -7.32%

Market Cap

$2.9 Million

USD as of Jan. 1, 2024

Market Cap History

Enveric Biosciences, Inc. market capitalization over time

Evolution of Enveric Biosciences, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Enveric Biosciences, Inc.

Detailed Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. It has a pipeline of development programs for radiodermatitis, glioblastoma multiforme, pruritus, rashes, and dry skin and chemotherapy-induced neuropathy. The company is headquartered in Naples, Florida.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Enveric Biosciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ENVB wb_incandescent

Details

Headquarters:

181 Bay Street

Suite 4400E

Toronto, ON M5J 2T3

Canada